Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Native Pet is a pet nutrition and wellness company that develops functional supplements and food toppers for dogs and cats. The company emphasizes a clean-label approach, utilizing whole-food ingredients and avoiding synthetic fillers or additives commonly found in traditional pet products. Their portfolio includes a variety of formats such as probiotic powders, omega oils, calming chews, and joint relief supplements designed to address specific health concerns. By combining veterinary insights with a direct-to-consumer business model, Native Pet aims to bridge the gap between basic nutrition and therapeutic support. The company has successfully expanded its presence from online platforms into major national retail chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Native Pet.